A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Breast Cancer
Interventions: DRUG: DS-1103a|DRUG: T-DXd
Sponsor: Daiichi Sankyo
Collaborators: AstraZeneca